Publications by authors named "Alex Allepuz"

Claim this Profile
H
Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trial.
Delphine Réa, Carla Boquimpani, Michael J Mauro, Yosuke Minami, Alex Allepuz

Leukemia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL.
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E Cortes, Alex Allepuz

Leukemia· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study.
Junichiro Yuda, Noriko Doki, Hiroshi Matsuoka, Takafumi Yokota, Akihiro Tomita, Alex Allepuz

Cancer Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Asciminib in Individuals With Hepatic or Renal Impairment.
Matthias Hoch, Masahiko Sato, Julia Zack, Michelle Quinlan, Tirtha Sengupta, Alex Allepuz

J Clin Pharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Delphine Réa, Michael J Mauro, Carla Boquimpani, Yosuke Minami, Elza Lomaia, Alex Allepuz

Blood· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of nilotinib in pediatric patients with CML: long-term update on growth retardation and safety.
Nobuko Hijiya, Alexey Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Alex Allepuz

Blood Adv· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia.
Nobuko Hijiya, Alexey Maschan, Carmelo Rizzari, Hiroyuki Shimada, Carlo Dufour, Alex Allepuz

Blood· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of femoral head size on metal-on-HXLPE hip arthroplasty outcome in a combined analysis of six national and regional registries.
Alex Allepuz, Leif Havelin, Thomas Barber, Art Sedrakyan, Stephen Graves

J Bone Joint Surg Am· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis